Browse EX-10 agreements

** **

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

P R O M I S S O R Y N O T E

Principal Amount: $180,000.00	Dated as of June 23, 2026

…

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

** **

AMENDED AND RESTATED PROMISSORY NOTE

Principal Amount: $20,000.00	Dated as of August 11, 2026

…

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

P R O M I S S O R Y N O T E

Principal Amount: $20,000.00	Dated as of June 23, 2026

…

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

** **

AMENDED AND RESTATED PROMISSORY NOTE

Principal Amount: $180,000.00	Dated as of August 11, 2026

…

**SOLV Energy, Inc. **

**2026 Equity Incentive Plan **

**Form of Restricted Stock Unit Award Agreement **

This Restricted Stock Unit Award Agreement (this “Agreement”) is made by and between SOLV Energy, Inc., a Delaware corporation (the “Company”), and _________________ (the “Participant”), effective as of ______________ (the “Date of Grant”).

***RECITALS ***

WHEREAS, the Company has adopted the SOLV Energy, Inc. 2026 Equity Incentive Plan (the “Plan”), which is incorporated herein by reference and made a part of this Agreement. Capitalized terms not otherwise defined in this Agreement shall have the meanings ascribed to those terms in the Plan; and

WHEREAS, the Committee has authorized and approved the grant of an Award to the Participant that will provide the Participant the opportunity to receive Common Stock upon the settlement of stock units on the terms and conditions set forth in the Plan and this Agreement (“Restricted Stock Units”).

…

Exhibit 10.12X

May 27, 2026

RE: OFFER OF EMPLOYMENT

Dear Ryan,

We are pleased to offer you employment with Maui Land & Pineapple Company, Inc. ("MLP," "Company," "we," "us," or "our"). Once you have signed and returned this letter to us, it will become a binding contract between you and the Company on the following terms and conditions:

1.***    Position: ***Your title will be Chief Investment Officer, reporting to the Chief Executive Officer ("CEO"). You will primarily work at the Company's offices located in Kapalua at 500 Office Road Lahaina, HI 96761 and in Hali’imaile at 870 Hali’imaile Road, Makawao, HI 96768, except when business matters require work to be performed at an alternate location. You may work remotely occasionally when business matters permit.

…

Exhibit 10.11X

***“Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain information marked with ***“**[**REDACTED]”*** has been omitted as it is (i) not material and (ii) is customarily and actually treated as private or confidential by the registrant.***”

PURCHASE AND SALE AGREEMENT

AND ESCROW INSTRUCTIONS

This Purchase and Sale Agreement and Escrow Instructions (“Agreement”) dated May 27, 2026 (the “Effective Date”) is made between MAUI LAND & PINEAPPLE COMPANY, INC., a Delaware corporation, as “Seller”, and DC KAPALUA 1 PROPERTY, LLC, a Delaware limited liability company, or permitted assignee, as “Buyer”, with reference to the following:

A.         Seller owns fee simple title to (i) Lot 2-D of the “Kapalua Makai Subdivision No. 1” located in Kapalua, Maui, Hawaii, containing approximately 382,587 square feet (approximately 8.783 acres) and identified by Tax Map Key No. (2) 4-2-004-068 (“Lot 2-D”) and (ii) Tax Map Key No. (2) 4-2-004-067 (“Adjacent Parcel”).

…

FIRST AMENDMENT TO LEASE

THIS FIRST AMENDMENT TO LEASE (“First Amendment”) is made and entered into as of the 10thday of August, 2026, by and between LG 1 PROPERTY OWNER LP, a Delaware limited partnership (“Landlord”), and CERENOME, INC., a Delaware corporation (“Tenant”).

R E C I T A L S:

A.

Landlord and Tenant entered into that certain Lease dated as of October 16, 2025 (the “Lease”), whereby Landlord leases to Tenant and Tenant leases from Landlord certain space located in that certain building located and addressed at 6420 Levit Green Boulevard, Houston, Texas (the “Building”). Tenant was formerly known as Plus Therapeutics, Inc. until it changed its name to Cerenome, Inc.

B.

By this First Amendment, Landlord and Tenant desire to restate the location and size of the Premises and to otherwise modify the Lease as provided herein.

C.

Unless otherwise defined herein, capitalized terms as used herein shall have the same meanings as given thereto in the Lease.

…

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Plus Therapeutics, Inc., a Delaware corporation (the “Company”), and Eric J. Daniels, M.D., M.B.A. (“Executive”), and shall be effective as of April 20, 2026 (the “Effective Date”).

WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by the Company, on the terms and conditions set forth in this Agreement.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties agree to the following:

1.

Definitions. As used in this Agreement, the following terms shall have the following meanings:

…

​

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE MAKER THAT SUCH REGISTRATION IS NOT REQUIRED.

​

CONVERTIBLE PROMISSORY NOTE (“NOTE”)

​

Principal Amount: $300,000
Dated: August 10, 2026

​

…

AGREEMENT

** **

This Agreement (the “Agreement”) is made effective as of August 14, 2026 (the “Effective Date”), by and between Fabric.AI, Inc., a Delaware corporation (the “Company”) and Michael Murray (the “Consultant”) (collectively, the Company and the Consultant shall be referred to as, the “Parties” or individually as a “Party”).

WHEREAS, the Company and Kopin Corporation entered into the Joint Development and License Agreement, dated April 27, 2026 (the “License”), pursuant to which the Joint Steering Committee (“JSC”) was established, and, since the execution of the License, the Consultant has been acting as Chairman of the JSC;

WHEREAS, the Parties acknowledge that both the Company and Kopin will receive benefits from the successful development and commercialization of the technology contemplated by the License; and

…

CERTAIN PORTIONS OF THIS EXHIBIT (INDICATED BY [***]) HAVE BEEN EXCLUDED PURSUANT TO ITEM 601(B)(10) OF REGULATION S-K BECAUSE THEY ARE BOTH NOT MATERIAL AND ARE THE TYPE THAT THE COMPANY TREATS AS PRIVATE AND CONFIDENTIAL.

FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT

This First Amendment to the Purchase and Sale Agreement (this “FirstAmendment”) is made as of May 1, 2026 (the “FirstAmendment Effective Date”), by and between Sagard Healthcare Partners Funding Borrower SPE 2, LP, a Delaware limited partnership (“Sagard”) and MacroGenics, Inc., a Delaware corporation (the “Seller”). Sagard and Seller are collectively referred to herein as the “Parties” and individually as a “Party.”

BACKGROUND

…